A survey of patients with Chlamydia trachomatis infection: sexual behaviour and perceptions about contact tracing. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


A survey of patients with Chlamydia trachomatis infection: sexual behaviour and perceptions about contact tracing.

Int J STD AIDS. 2000 Feb;11(2):92-5. Unique Identifier : AIDSLINE MED/20141944
Tyden T; Ramstedt K; Department of Public Health and Caring Sciences, University of; Uppsala, Sweden. tanja.tyden@vard.uu.se


Abstract: The aim of this study was to evaluate how patients with Chlamydia trachomatis infection perceived the legal enforcement of partner notification and to seek their views on legislation impinging on their own sexual behaviour. The investigation was performed at STD clinics in Stockholm, Sweden in 1997. Consecutive patients (n=192) answered a questionnaire about sexual behaviour and contact tracing. More men (40%) than women (21%) had had sexual intercourse during the past 6 months with an occasional partner. The mean number (6 months prior to this) was 2.3 partners (1-15) for men and 2.2 partners (1-21) for women. Eighteen per cent admitted to having avoided disclosing the name of their partner(s). Ninety per cent considered it beneficial that chlamydial infection was regulated and that a named partner could be forced to undergo STD testing. Partly based on this report, the government has recommended police enforcement to be removed from the legislation as a tool for contact tracing in chlamydial infections.
Keywords: JOURNAL ARTICLE Adolescence Adult *Chlamydia trachomatis Chlamydia Infections/PREVENTION & CONTROL/*TRANSMISSION Contraception Female Human Male Middle Age Perception *Sex BehaviorKWDjournalarticleadolescenceadultKWDchlamydiatrachomatischlamydiainfections/prevention&control/KWDtransmissioncontraceptionfemalehumanmalemiddleageperceptionKWDsexbehavior
000530
A0052218

Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .